Big pharma better buy soon. This company's IP is worth about $5B to $10B right now, IMO. If in 6-12 months time, Regen provides any kind of proof of concept, then the price for a buyout goes up dramatically. If big pharma wants it cheap, they need to pony up the cash in the next month or two.